Dr. DeFronzo discusses treatments based on our understanding of the pathophysiology of T2DM.
Dr. DeFronzo discusses pharmacologic therapy vs. lifestyle intervention.
Cardiometabolic pioneer, Dr. DeFronzo, discusses cardiovascular outcomes data & practical information on management.
Endocrinologist discusses new GLP1 meds to help lower blood sugar
Experts discuss managing CVD with medications typically used for DM
Dr. Rodney Horton on optimizing workflow within the EP lab from the Abbott Cardio booth at #HRS2019